{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:51:04Z","timestamp":1793789464359,"version":"4.6.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>N7-methylguanosine (m<jats:sup>7<\/jats:sup>G) modification of transfer RNA (tRNA) is essential for the biological functions of tRNAs and has been found to play a regulatory role in a variety of human cancers. However, the biological function of METTL1-mediated m<jats:sup>7<\/jats:sup>G tRNA modification in papillary thyroid cancer (PTC) is unclear. Here, we found that METTL1 is significantly upregulated in PTC tissues compared to normal control tissues and is associated with poor PTC prognosis. Functional analysis confirmed that METTL1 promotes the proliferation and metastasis of PTC cells in a manner dependent on its tRNA methyltransferase activity. Mechanistically, METTL1 knockdown leads to a decrease in the abundance of certain m<jats:sup>7<\/jats:sup>G-modified tRNAs, which suppresses the m<jats:sup>7<\/jats:sup>G tRNA modification-mediated codon-specific translation of TNF-\u03b1. Furthermore, exogenous supplementation with TNF-\u03b1 partially reversed the decrease in the proliferation and metastasis of PTC cells induced by METTL1 deletion. Positive correlations between METTL1, WDR4, and TNF-\u03b1 expression, which affect the proliferation and metastasis of PTC, were confirmed via analysis of microarrays containing PTC tissues. These results demonstrate the oncogenic role of METTL1-mediated m<jats:sup>7<\/jats:sup>G tRNA modification in regulating codon-specific translation efficiency in PTC and suggest that targeting METTL1 may be a promising therapeutic approach for overcoming PTC progression by inhibiting PTC cell proliferation and metastasis.<\/jats:p>","DOI":"10.1038\/s41419-025-07716-8","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:36:51Z","timestamp":1747175811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["METTL1-mediated m7G tRNA modification drives papillary thyroid cancer progression and metastasis by regulating the codon-specific translation of TNF-\u03b1"],"prefix":"10.1038","volume":"16","author":[{"given":"Weiwei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiwang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengkai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4858-5337","authenticated-orcid":false,"given":"Cen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0132-6673","authenticated-orcid":false,"given":"Xiangjin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5588-3777","authenticated-orcid":false,"given":"Sunwang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"7716_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"7716_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","volume":"10","author":"M Pizzato","year":"2022","unstructured":"Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022;10:264\u201372.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"7716_CR3","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA. 2017;317:1338.","journal-title":"JAMA"},{"key":"7716_CR4","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1089\/thy.2021.0662","volume":"32","author":"UC Megwalu","year":"2022","unstructured":"Megwalu UC, Moon PK. Thyroid cancer incidence and mortality trends in the United States: 2000-2018. Thyroid. 2022;32:560\u201370.","journal-title":"Thyroid"},{"key":"7716_CR5","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Thyroid cancer. Lancet. 2023;401:1531\u201344.","journal-title":"Lancet"},{"key":"7716_CR6","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1089\/thy.2013.0610","volume":"24","author":"M Zou","year":"2014","unstructured":"Zou M, Baitei EY, Alzahrani AS, BinHumaid FS, Alkhafaji D, Al-Rijjal RA, et al. Concomitant RAS, RET\/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma. Thyroid. 2014;24:1256\u201366.","journal-title":"Thyroid"},{"key":"7716_CR7","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.ymthe.2021.01.019","volume":"29","author":"J He","year":"2021","unstructured":"He J, Zhou M, Yin J, Wan J, Chu J, Jia J, et al. METTL3 restrains papillary thyroid cancer progression via m6A\/c-Rel\/IL-8-mediated neutrophil infiltration. Mol Ther. 2021;29:1821\u201337.","journal-title":"Mol Ther"},{"key":"7716_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-10-175","volume":"13","author":"Y Saletore","year":"2012","unstructured":"Saletore Y, Meyer K, Korlach J, Vilfan ID, Jaffrey S, Mason CE. The birth of the Epitranscriptome: deciphering the function of RNA modifications. Genome Biol. 2012;13:175.","journal-title":"Genome Biol"},{"key":"7716_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molmed.2014.01.008","volume":"20","author":"AG Torres","year":"2014","unstructured":"Torres AG, Batlle E, Ribas de Pouplana L. Role of tRNA modifications in human diseases. Trends Mol Med. 2014;20:306\u201314.","journal-title":"Trends Mol Med"},{"key":"7716_CR10","doi-asserted-by":"publisher","first-page":"D231","DOI":"10.1093\/nar\/gkab1083","volume":"50","author":"P Boccaletto","year":"2022","unstructured":"Boccaletto P, Stefaniak F, Ray A, Cappannini A, Mukherjee S, Purta E, et al. MODOMICS: a database of RNA modification pathways. 2021 update. Nucleic Acids Res. 2022;50:D231\u20135.","journal-title":"Nucleic Acids Res"},{"key":"7716_CR11","doi-asserted-by":"crossref","first-page":"D202","DOI":"10.1093\/nar\/gkx1030","volume":"46","author":"P Boccaletto","year":"2018","unstructured":"Boccaletto P, Magnus M, Almeida C, Zyla A, Astha A, Pluta R, et al. RNArchitecture: a database and a classification system of RNA families, with a focus on structural information. Nucleic Acids Res. 2018;46:D202\u20135.","journal-title":"Nucleic Acids Res"},{"key":"7716_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.20892\/j.issn.2095-3941.2018.0365","volume":"15","author":"PinelloN Sun","year":"2018","unstructured":"Sun PinelloN, Wong S. JJ-L. Aberrant expression of enzymes regulating m6A mRNA methylation: implication in cancer. Cancer Biol Med. 2018;15:323\u201334.","journal-title":"Cancer Biol Med"},{"key":"7716_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1033-z","volume":"18","author":"X-Y Chen","year":"2019","unstructured":"Chen X-Y, Zhang J, Zhu J-S. The role of m6A RNA methylation in human cancer. Mol Cancer. 2019;18:103.","journal-title":"Mol Cancer"},{"key":"7716_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12921","volume":"53","author":"F-C Huo","year":"2020","unstructured":"Huo F-C, Zhu Z-M, Pei D-S. N6 -methyladenosine (m6A) RNA modification in human cancer. Cell Prolif. 2020;53:e12921.","journal-title":"Cell Prolif"},{"key":"7716_CR15","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23:1369\u201376.","journal-title":"Nat Med"},{"key":"7716_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature24678","volume":"552","author":"I Barbieri","year":"2017","unstructured":"Barbieri I, Tzelepis K, Pandolfini L, Shi J, Mill\u00e1n-Zambrano G, Robson SC, et al. Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control. Nature. 2017;552:126\u201331.","journal-title":"Nature"},{"key":"7716_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin S, Choe J, Du P, Triboulet R, Gregory RI. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62:335\u201345.","journal-title":"Mol Cell"},{"key":"7716_CR18","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/hep.28885","volume":"65","author":"J-Z Ma","year":"2017","unstructured":"Ma J-Z, Yang F, Zhou C-C, Liu F, Yuan J-H, Wang F, et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6-methyladenosine-dependent primary MicroRNA processing. Hepatology. 2017;65:529\u201343.","journal-title":"Hepatology"},{"key":"7716_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrm.2017.77","volume":"19","author":"P Schimmel","year":"2018","unstructured":"Schimmel P. The emerging complexity of the tRNA world: mammalian tRNAs beyond protein synthesis. Nat Rev Mol Cell Biol. 2018;19:45\u201358.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7716_CR20","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1101\/gad.1956510","volume":"24","author":"EM Phizicky","year":"2010","unstructured":"Phizicky EM, Hopper AK. tRNA biology charges to the front. Genes Dev. 2010;24:1832\u201360.","journal-title":"Genes Dev"},{"key":"7716_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1006\/geno.2000.6258","volume":"68","author":"J Michaud","year":"2000","unstructured":"Michaud J, Kudoh J, Berry A, Bonne-Tamir B, Lalioti MD, Rossier C, et al. Isolation and characterization of a human chromosome 21q22.3 Gene (WDR4) and its mouse homologue that code for a WD-repeat protein. Genomics. 2000;68:71\u20139.","journal-title":"Genomics"},{"key":"7716_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1086\/422507","volume":"75","author":"K Freude","year":"2004","unstructured":"Freude K, Hoffmann K, Jensen L-R, Delatycki MB, des Portes V, Moser B, et al. Mutations in the FTSJ1 gene coding for a novel S-adenosylmethionine-binding protein cause nonsyndromic X-linked mental retardation. Am J Hum Genet. 2004;75:305\u20139.","journal-title":"Am J Hum Genet"},{"key":"7716_CR23","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1136\/jmg.2004.019000","volume":"41","author":"J Ramser","year":"2004","unstructured":"Ramser J, Winnepenninckx B, Lenski C, Errijgers V, Platzer M, Schwartz CE, et al. A splice site mutation in the methyltransferase gene FTSJ1 in Xp11.23 is associated with non-syndromic mental retardation in a large Belgian family (MRX9). J Med Genet. 2004;41:679\u201383.","journal-title":"J Med Genet"},{"key":"7716_CR24","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.cub.2006.04.027","volume":"16","author":"M Frye","year":"2006","unstructured":"Frye M, Watt FM. The RNA methyltransferase Misu (NSun2) mediates Myc-induced proliferation and is upregulated in tumors. Curr Biol. 2006;16:971\u201381.","journal-title":"Curr Biol"},{"key":"7716_CR25","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.1158\/0008-5472.CAN-09-0458","volume":"69","author":"M Schaefer","year":"2009","unstructured":"Schaefer M, Hagemann S, Hanna K, Lyko F. Azacytidine inhibits RNA methylation at DNMT2 target sites in human cancer cell lines. Cancer Res. 2009;69:8127\u201332.","journal-title":"Cancer Res"},{"key":"7716_CR26","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1507\/endocrj.EJ11-0099","volume":"58","author":"F-Y Wei","year":"2011","unstructured":"Wei F-Y, Tomizawa K. Functional loss of Cdkal1, a novel tRNA modification enzyme, causes the development of type 2 diabetes. Endocr J. 2011;58:819\u201325.","journal-title":"Endocr J"},{"key":"7716_CR27","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1074\/jbc.275.6.4251","volume":"275","author":"T Yasukawa","year":"2000","unstructured":"Yasukawa T, Suzuki T, Suzuki T, Ueda T, Ohta S, Watanabe K. Modification defect at anticodon wobble nucleotide of mitochondrial tRNAsLeu(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. J Biol Chem. 2000;275:4251\u20137.","journal-title":"J Biol Chem"},{"key":"7716_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0014-5793(00)01145-5","volume":"467","author":"T Yasukawa","year":"2000","unstructured":"Yasukawa T, Suzuki T, Ishii N, Ueda T, Ohta S, Watanabe K. Defect in modification at the anticodon wobble nucleotide of mitochondrial tRNA(Lys) with the MERRF encephalomyopathy pathogenic mutation. FEBS Lett. 2000;467:175\u20138.","journal-title":"FEBS Lett"},{"key":"7716_CR29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1261\/rna.2030705","volume":"11","author":"A Alexandrov","year":"2005","unstructured":"Alexandrov A, Grayhack EJ, Phizicky EM. tRNA m7G methyltransferase Trm8p\/Trm82p: evidence linking activity to a growth phenotype and implicating Trm82p in maintaining levels of active Trm8p. RNA. 2005;11:821\u201330.","journal-title":"RNA"},{"key":"7716_CR30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.molcel.2018.06.001","volume":"71","author":"S Lin","year":"2018","unstructured":"Lin S, Liu Q, Lelyveld VS, Choe J, Szostak JW, Gregory RI. Mettl1\/Wdr4-mediated m7G tRNA methylome is required for normal mRNA translation and embryonic stem cell self-renewal and differentiation. Mol Cell. 2018;71:244\u201355.e5.","journal-title":"Mol Cell"},{"key":"7716_CR31","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.molcel.2019.06.004","volume":"74","author":"K Boulias","year":"2019","unstructured":"Boulias K, Greer EL. Put the Pedal to the METTL1: adding internal m7G increases mRNA translation efficiency and augments miRNA processing. Mol Cell. 2019;74:1105\u20137.","journal-title":"Mol Cell"},{"key":"7716_CR32","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1017\/S1355838202024019","volume":"8","author":"A Alexandrov","year":"2002","unstructured":"Alexandrov A, Martzen MR, Phizicky EM. Two proteins that form a complex are required for 7-methylguanosine modification of yeast tRNA. RNA. 2002;8:1253\u201366.","journal-title":"RNA"},{"key":"7716_CR33","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1016\/j.molcel.2021.07.003","volume":"81","author":"Z Dai","year":"2021","unstructured":"Dai Z, Liu H, Liao J, Huang C, Ren X, Zhu W, et al. N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression. Mol Cell. 2021;81:3339\u20133355.e8.","journal-title":"Mol Cell"},{"key":"7716_CR34","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1016\/j.molcel.2021.06.031","volume":"81","author":"EA Orellana","year":"2021","unstructured":"Orellana EA, Liu Q, Yankova E, Pirouz M, De Braekeleer E, Zhang W, et al. METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation. Mol Cell. 2021;81:3323\u201338.e14.","journal-title":"Mol Cell"},{"key":"7716_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15749-z","volume":"7","author":"D Yan","year":"2017","unstructured":"Yan D, Tu L, Yuan H, Fang J, Cheng L, Zheng X, et al. WBSCR22 confers oxaliplatin resistance in human colorectal cancer. Sci Rep. 2017;7:15443.","journal-title":"Sci Rep"},{"key":"7716_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29125-7","volume":"13","author":"H Han","year":"2022","unstructured":"Han H, Yang C, Ma J, Zhang S, Zheng S, Ling R, et al. N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR\/ULK1\/autophagy axis. Nat Commun. 2022;13:1478.","journal-title":"Nat Commun"},{"key":"7716_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/cac2.12273","volume":"42","author":"J Chen","year":"2022","unstructured":"Chen J, Li K, Chen J, Wang X, Ling R, Cheng M, et al. Aberrant translation regulated by METTL1\/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression. Cancer Commun. 2022;42:223\u201344.","journal-title":"Cancer Commun"},{"key":"7716_CR38","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1038\/s41596-019-0226-7","volume":"14","author":"S Lin","year":"2019","unstructured":"Lin S, Liu Q, Jiang Y-Z, Gregory RI. Nucleotide resolution profiling of m7G tRNA modification by TRAC-Seq. Nat Protoc. 2019;14:3220\u201342.","journal-title":"Nat Protoc"},{"key":"7716_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13420-x","volume":"10","author":"S Xu","year":"2019","unstructured":"Xu S, Zhan M, Jiang C, He M, Yang L, Shen H, et al. Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer. Nat Commun. 2019;10:5492.","journal-title":"Nat Commun"},{"key":"7716_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93526-9","volume":"11","author":"H He","year":"2021","unstructured":"He H, Liyanarachchi S, Li W, Comiskey DF, Yan P, Bundschuh R, et al. Transcriptome analysis discloses dysregulated genes in normal appearing tumor-adjacent thyroid tissues from patients with papillary thyroid carcinoma. Sci Rep. 2021;11:14126.","journal-title":"Sci Rep"},{"key":"7716_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102538","volume":"58","author":"D Lu","year":"2022","unstructured":"Lu D, Lin Z, Wang R, Chen Z, Zhuo J, Xu L, et al. Multi-omics profiling reveals Chitinase-3-like protein 1 as a key mediator in the crosstalk between sarcopenia and liver cancer. Redox Biol. 2022;58:102538.","journal-title":"Redox Biol"},{"key":"7716_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02516-9","volume":"19","author":"B Gong","year":"2022","unstructured":"Gong B, Guo D, Zheng C, Ma Z, Zhang J, Qu Y, et al. Complement C3a activates astrocytes to promote medulloblastoma progression through TNF-\u03b1. J Neuroinflammation. 2022;19:159.","journal-title":"J Neuroinflammation"},{"key":"7716_CR43","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.7150\/jca.53349","volume":"12","author":"N Lv","year":"2021","unstructured":"Lv N, Liu F, Cheng L, Liu F, Kuang J. The expression of transcription factors is different in papillary thyroid cancer cells during TNF - \u03b1 induced EMT. J Cancer. 2021;12:2777\u201386.","journal-title":"J Cancer"},{"key":"7716_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.675","volume":"11","author":"X Ying","year":"2021","unstructured":"Ying X, Liu B, Yuan Z, Huang Y, Chen C, Jiang X, et al. METTL1-m7 G-EGFR\/EFEMP1 axis promotes the bladder cancer development. Clin Transl Med. 2021;11:e675.","journal-title":"Clin Transl Med"},{"key":"7716_CR45","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.chembiol.2007.08.012","volume":"14","author":"TL Gururaja","year":"2007","unstructured":"Gururaja TL, Yung S, Ding R, Huang J, Zhou X, McLaughlin J, et al. A class of small molecules that inhibit TNF\u03b1-induced survival and death pathways via prevention of interactions between TNF\u03b1RI, TRADD, and RIP1. Chem Biol. 2007;14:1105\u201318.","journal-title":"Chem Biol"},{"key":"7716_CR46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2019.12.023","volume":"180","author":"DP Nusinow","year":"2020","unstructured":"Nusinow DP, Szpyt J, Ghandi M, Rose CM, McDonald ER, Kalocsay M, et al. Quantitative proteomics of the cancer cell line encyclopedia. Cell. 2020;180:387\u2013402.e16.","journal-title":"Cell"},{"key":"7716_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature10098","volume":"473","author":"B Schwanh\u00e4usser","year":"2011","unstructured":"Schwanh\u00e4usser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, et al. Global quantification of mammalian gene expression control. Nature. 2011;473:337\u201342.","journal-title":"Nature"},{"key":"7716_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.molcel.2005.10.036","volume":"21","author":"A Alexandrov","year":"2006","unstructured":"Alexandrov A, Chernyakov I, Gu W, Hiley SL, Hughes TR, Grayhack EJ, et al. Rapid tRNA decay can result from lack of nonessential modifications. Mol Cell. 2006;21:87\u201396.","journal-title":"Mol Cell"},{"key":"7716_CR49","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1038\/s41388-022-02250-9","volume":"41","author":"B Chen","year":"2022","unstructured":"Chen B, Jiang W, Huang Y, Zhang J, Yu P, Wu L, et al. N7-methylguanosine tRNA modification promotes tumorigenesis and chemoresistance through WNT\/\u03b2-catenin pathway in nasopharyngeal carcinoma. Oncogene. 2022;41:2239\u201353.","journal-title":"Oncogene"},{"key":"7716_CR50","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.gendis.2023.04.011","volume":"11","author":"H Jiang","year":"2023","unstructured":"Jiang H, Liu Y, Song H, Xia J, Tian Y, Wang L, et al. METTL1 promotes colorectal cancer cell proliferation by attenuating CHEK2-induced G1\/S phase arrest. Genes Dis. 2023;11:579\u201381.","journal-title":"Genes Dis"},{"key":"7716_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.661","volume":"11","author":"Z Chen","year":"2021","unstructured":"Chen Z, Zhu W, Zhu S, Sun K, Liao J, Liu H, et al. METTL1 promotes hepatocarcinogenesis via m7G tRNA modification-dependent translation control. Clin Transl Med. 2021;11:e661.","journal-title":"Clin Transl Med"},{"key":"7716_CR52","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.cell.2016.05.046","volume":"165","author":"H Goodarzi","year":"2016","unstructured":"Goodarzi H, Nguyen HCB, Zhang S, Dill BD, Molina H, Tavazoie SF. Modulated expression of specific tRNAs drives gene expression and cancer progression. Cell. 2016;165:1416\u201327.","journal-title":"Cell"},{"key":"7716_CR53","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00109-019-01830-9","volume":"97","author":"Q-H Tian","year":"2019","unstructured":"Tian Q-H, Zhang M-F, Zeng J-S, Luo R-G, Wen Y, Chen J, et al. METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN. J Mol Med. 2019;97:1535\u201345.","journal-title":"J Mol Med"},{"key":"7716_CR54","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/ijc.2910380521","volume":"38","author":"PG Brouckaert","year":"1986","unstructured":"Brouckaert PG, Leroux-Roels GG, Guisez Y, Tavernier J, Fiers W. In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma. Int J Cancer. 1986;38:763\u20139.","journal-title":"Int J Cancer"},{"key":"7716_CR55","first-page":"3990","volume":"46","author":"FR Balkwill","year":"1986","unstructured":"Balkwill FR, Lee A, Aldam G, Moodie E, Thomas JA, Tavernier J, et al. Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Cancer Res. 1986;46:3990\u20133.","journal-title":"Cancer Res"},{"key":"7716_CR56","first-page":"544","volume":"48","author":"JE Talmadge","year":"1988","unstructured":"Talmadge JE, Phillips H, Schneider M, Rowe T, Pennington R, Bowersox O, et al. Immunomodulatory properties of recombinant murine and human tumor necrosis factor. Cancer Res. 1988;48:544\u201350.","journal-title":"Cancer Res"},{"key":"7716_CR57","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/329630a0","volume":"329","author":"SJ Leibovich","year":"1987","unstructured":"Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature. 1987;329:630\u20132.","journal-title":"Nature"},{"key":"7716_CR58","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1038\/sj.bjc.6601814","volume":"90","author":"V Michalaki","year":"2004","unstructured":"Michalaki V, Syrigos K, Charles P, Waxman J. Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer. 2004;90:2312\u20136.","journal-title":"Br J Cancer"},{"key":"7716_CR59","first-page":"4516","volume":"59","author":"M Suganuma","year":"1999","unstructured":"Suganuma M, Okabe S, Marino MW, Sakai A, Sueoka E, Fujiki H. Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. Cancer Res. 1999;59:4516\u20138.","journal-title":"Cancer Res"},{"key":"7716_CR60","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1158\/0008-5472.CAN-06-2941","volume":"67","author":"H Kulbe","year":"2007","unstructured":"Kulbe H, Thompson R, Wilson JL, Robinson S, Hagemann T, Fatah R, et al. The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells. Cancer Res. 2007;67:585\u201392.","journal-title":"Cancer Res"},{"key":"7716_CR61","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1158\/0008-5472.CAN-07-5704","volume":"68","author":"J-H Egberts","year":"2008","unstructured":"Egberts J-H, Cloosters V, Noack A, Schniewind B, Thon L, Klose S, et al. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. Cancer Res. 2008;68:1443\u201350.","journal-title":"Cancer Res"},{"key":"7716_CR62","doi-asserted-by":"publisher","first-page":"9825","DOI":"10.1158\/0008-5472.CAN-07-1064","volume":"67","author":"GT Stathopoulos","year":"2007","unstructured":"Stathopoulos GT, Kollintza A, Moschos C, Psallidas I, Sherrill TP, Pitsinos EN, et al. Tumor necrosis factor-\u03b1 promotes malignant pleural effusion. Cancer Res. 2007;67:9825\u201334.","journal-title":"Cancer Res"},{"key":"7716_CR63","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1158\/0008-5472.CAN-06-2295","volume":"67","author":"K Zins","year":"2007","unstructured":"Zins K, Abraham D, Sioud M, Aharinejad S. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway. Cancer Res. 2007;67:1038\u201345.","journal-title":"Cancer Res"},{"key":"7716_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14091","volume":"8","author":"X Wang","year":"2017","unstructured":"Wang X, Chen H, Tian R, Zhang Y, Drutskaya MS, Wang C, et al. Macrophages induce AKT\/\u03b2-catenin-dependent Lgr5+ stem cell activation and hair follicle regeneration through TNF. Nat Commun. 2017;8:14091.","journal-title":"Nat Commun"},{"key":"7716_CR65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41536-023-00296-1","volume":"8","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Ye Z, Wei W, Zhang M, Huang F, Li J, et al. Macrophages maintain mammary stem cell activity and mammary homeostasis via TNF-\u03b1-PI3K-Cdk1\/Cyclin B1 axis. NPJ Regen Med. 2023;8:23.","journal-title":"NPJ Regen Med"},{"key":"7716_CR66","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/s13287-022-03178-3","volume":"13","author":"C Xu","year":"2022","unstructured":"Xu C, Feng C, Huang P, Li Y, Liu R, Liu C, et al. TNF\u03b1 and IFN\u03b3 rapidly activate PI3K-AKT signaling to drive glycolysis that confers mesenchymal stem cells enhanced anti-inflammatory property. Stem Cell Res Ther. 2022;13:491.","journal-title":"Stem Cell Res Ther"},{"key":"7716_CR67","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/sj.bjc.6605530","volume":"102","author":"Y Wu","year":"2010","unstructured":"Wu Y, Zhou BP. TNF-alpha\/NF-kappaB\/Snail pathway in cancer cell migration and invasion. Br J Cancer. 2010;102:639\u201344.","journal-title":"Br J Cancer"},{"key":"7716_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-97","volume":"9","author":"S-S Han","year":"2010","unstructured":"Han S-S, Yun H, Son D-J, Tompkins VS, Peng L, Chung S-T, et al. NF-kappaB\/STAT3\/PI3K signaling crosstalk in iMyc E mu B lymphoma. Mol Cancer. 2010;9:97.","journal-title":"Mol Cancer"},{"key":"7716_CR69","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/cncr.21653","volume":"106","author":"CI Lundgren","year":"2006","unstructured":"Lundgren CI, Hall P, Dickman PW, Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer. 2006;106:524\u201331.","journal-title":"Cancer"},{"key":"7716_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10669-0","volume":"10","author":"S Yang","year":"2019","unstructured":"Yang S, Wei J, Cui Y-H, Park G, Shah P, Deng Y, et al. m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nat Commun. 2019;10:2782.","journal-title":"Nat Commun"},{"key":"7716_CR71","doi-asserted-by":"publisher","first-page":"20159","DOI":"10.1073\/pnas.1918986117","volume":"117","author":"N Li","year":"2020","unstructured":"Li N, Kang Y, Wang L, Huff S, Tang R, Hui H, et al. ALKBH5 regulates anti\u2013PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proc Natl Acad Sci USA. 2020;117:20159\u201370.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07716-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07716-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07716-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:03:36Z","timestamp":1747181016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07716-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7716"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07716-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All methods were carried out in accordance with the Declaration of Helsinki and other relevant guidelines and regulations. This study was approved by the Ethics Committee of First Affiliated Hospital of Fujian Medical University (approved number: 2022-072). All of the subjects in this study were provided with written informed consent before enrollment. All animal experiment procedures were performed in accordance with the Animal Ethics Committee of Fujian Medical University (IACUC FJMU 2023-0343).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"378"}}